Recombinant Human CD22 protein, His-tagged, APC labeled
Cat.No. : | CD22-3947HA |
Product Overview : | Recombinant Human CD22 protein, His-tagged was Conjugated with NH2-Reactive APC(Allophycocyanin). |
Availability | February 17, 2025 |
Unit | |
Price | |
Qty |
- Specification
- Gene Information
- Related Products
- Download
Description : | NH2-Reactive Allophycocyanin is used for antibody conjugation for immunostaining and cellular proteins for tracing. NH2-Reactive Allophycocyanin has succinimidyl ester groups, and can easily make a covalent bond with amino groups of protein without any activation process. |
Source : | HEK293 Cells |
Species : | Human |
Tag : | His |
Form : | Liquid in sterile PBS buffer pH 7.4 (may contains tiny amount of reaction buffer and Allophycocyanin). |
Endotoxin : | <1EU/ug by LAL method. |
Stability : | Sample is stable for at least 12 months when stored at -20 to -80 centigrade from date of manufacture. For longer storage, add equal volume of glycerol to the sample solution and store at -20 to -80 centigrade. |
Storage : | Store under sterile conditions at -20 to -80 centigrade immediately after receipt. It is recommended that the protein be aliquoted for optimal storage. Avoid freeze-thaw cycles. |
Related Product : | CD22-3947H |
Gene Name : | CD22 CD22 molecule [ Homo sapiens ] |
Official Symbol : | CD22 |
Synonyms : | CD22; CD22 molecule; CD22 antigen; SIGLEC 2; SIGLEC2; BL-CAM; SIGLEC-2; FLJ22814; MGC130020; |
Gene ID : | 933 |
mRNA Refseq : | NM_001185099 |
Protein Refseq : | NP_001172028 |
MIM : | 107266 |
UniProt ID : | P20273 |
Products Types
◆ Recombinant Protein | ||
CD22-532H | Recombinant Human CD22 Protein (Trp176-Arg687), His-tagged, Biotinylated | +Inquiry |
CD22-01H | Recombinant Human CD22 Protein, hFc, Avi tagged, Biotinylated | +Inquiry |
CD22-442H | Recombinant Human CD22 Protein, His-tagged | +Inquiry |
CD22-15H | Recombinant Human CD22 Protein, His (Fc)-Avi-tagged | +Inquiry |
CD22-441H | Recombinant Human CD22 Protein, His-tagged | +Inquiry |
◆ Lysates | ||
CD22-001MCL | Recombinant Mouse CD22 cell lysate | +Inquiry |
CD22-1956HCL | Recombinant Human CD22 cell lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewThe CD22 protein offers numerous advantages in trials and research studies, making it an excellent choice for scientists in need of reliable and high-quality experimental materials.
Its unique properties make CD22 an invaluable tool for investigating cellular signaling pathways, protein-protein interactions, and membrane dynamics.
With the CD22 protein and its accompanying technical assistance, I am confident that I can achieve successful outcomes for my research endeavors.
Q&As (5)
Ask a questionCD22-targeted immunotherapy is more targeted, specifically attacking cancer cells, whereas chemotherapy affects both healthy and cancerous cells.
Yes, CD22-targeted therapies are often used in combination with chemotherapy or other immunotherapies for enhanced efficacy.
CD22-targeted therapies are being explored for autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus.
Yes, CD22 is targeted in immunotherapy for B cell malignancies like acute lymphoblastic leukemia (ALL).
CD22 acts as an inhibitory receptor, regulating B cell activation and signaling.
Ask a Question for All CD22 Products
Required fields are marked with *
My Review for All CD22 Products
Required fields are marked with *
Inquiry Basket